<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cialis</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cialis'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cialis%22&t=%22cialis%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:11:02 +0100</lastBuildDate>
        <item>
            <title>Pfizer Hacking &amp; Pharma Ineptness: Meyer Explains</title>
            <link>http://www.medworm.com/index.php?rid=5078037&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FzlP6m6NMZek%2F</link>
            <description>Last week, the Pfizer Facebook page was hacked by ScriptKiddies, setting off a flurry of chatter about not just hacking, but the extent to which this episode would affect the way drugmakers view the virtues of Facebook and, beyond that, social media (back story). This happened just as Facebook changes it rules so that drugmakers will no longer be allowed to disable comments, prompting some to consider walking away from Facebook (see this and this). We spoke with Rich Meyer, a former Eli Lilly marketer who worked on the Prozac and Cialis brand teams, and now runs Online Strategic Solutions and the World of DTC Marketing blog, for his thoughts on the implications&amp;#8230;
Pharmalot: How bad was the hacking incident?
Meyer: For consumers and patients, I don’t think it was that bad. They know ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5078037</comments>
            <pubDate>Thu, 28 Jul 2011 13:23:23 +0100</pubDate>
            <guid isPermaLink="false">5078037</guid>        </item>
        <item>
            <title>What? I Can’t Hear You! Viagra Makes You Deaf?</title>
            <link>http://www.medworm.com/index.php?rid=4841983&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FwGS0Lq_faZk%2F</link>
            <description>For the second time in the past year, a study has been released indicating that the little blue impotence pill can not only make one hard, but hard of hearing. To be specific, the trio of popular meds for erectile dysfunction - Viagra, Cialis and Levitra - were linked to 47 suspected cases of sensorineural hearing loss – a rapid loss of hearing in one or both ears that can become permanent, according to a study in The Laryngoscope.
The UK researchers reviewed info from published literature and regulatory reports around the globe for incidents that may have been triggered by the pills. They found that hearing loss occurred within 24 hours of ingestion in nearly 67 percent of the cases, with Pfizer&amp;#8217;s Viagra accounting for more than half of the total. The average age of those affected...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4841983</comments>
            <pubDate>Thu, 19 May 2011 12:52:19 +0100</pubDate>
            <guid isPermaLink="false">4841983</guid>        </item>
        <item>
            <title>Medicare Dollars Paid For Grandpa’s Viagra</title>
            <link>http://www.medworm.com/index.php?rid=4592690&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXgxfoXXmECM%2F</link>
            <description>How has Medicare been spending taxpayer dollars these last few years? What would you say if the federally funded health care program dished out more than $3.1 million to buy Pfizer&amp;#8217;s Viagra and other impotence pills for seniors? Well, that&amp;#8217;s what happened in 2007 and 2008, according to a new report from the US Department of Health &amp;#038; Human Services Office of the Inspector General.
As you might imagine, this was not supposed to happen. Medicare “should not have covered these drugs,” George Reeb, acting deputy inspector general for audit services at the HHS wrote in a report released yesterday. And he recommended that the Centers for Medicare &amp;#038; Medicaid Services work with the FDA to maintain and distribute a list of prohibited drugs. 
But what went wrong? The CMS bra...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4592690</comments>
            <pubDate>Tue, 15 Mar 2011 12:15:46 +0100</pubDate>
            <guid isPermaLink="false">4592690</guid>        </item>
        <item>
            <title>Which Product Websites Prompt Consumers To Act?</title>
            <link>http://www.medworm.com/index.php?rid=4424446&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F9T5uMwVXXjQ%2F</link>
            <description>The list of product web sites that manage to get consumers to actually do something contains some very familiar names, such as Viagra, Nexium, Yaz and Lunesta. Of course, these are used to treat rather common concerns and all have, at one time or another, been widely advertised. Yet they also share something else in common - often, coupons are available, according to a recent survey that found, on average, 74 percent of consumers took some type of action after visiting a product web site.
In other words, coupons appear to act as a motivator for following up in some fashion. &amp;#8220;One thing we see when looking at satisfaction in years past is that there seems to be a high correlation beween satisfaction and a coupon,&amp;#8221; says Meredith Ressi, president of Manhattan Research, which canvas...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4424446</comments>
            <pubDate>Tue, 01 Feb 2011 14:04:32 +0100</pubDate>
            <guid isPermaLink="false">4424446</guid>        </item>
        <item>
            <title>How FDA Warnings &amp; DTC Advertising Increase Sales of Sexual Enhancement Dietary Supplements</title>
            <link>http://www.medworm.com/index.php?rid=4031500&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F10%2Fhow-fda-warnings-dtc-advertising.html</link>
            <description>Here's an example of how the Internet and direct-to-consumer (DTC) advertising empowers consumers.For several years now the FDA has been issuing warnings to consumers about &quot;dietary supplements&quot; that claim to enhance sexual performance or treat erectile dysfunction. According to the FDA, although it has issued &quot;many alerts about these types of supplements over the past several years, ... their number seems to be growing&quot; (see &quot;FDA Consumer Corner: Cautions about Sexual Enhancement Products&quot;).Using the Internet, FDA now has a much more direct line of communication to consumers. And consumers use the Internet to buy dietary supplements. This concerns drug companies and the FDA.What concerns the FDA about these products? FDA states:&quot;FDA has found that many of these supposedly 'all natural' pr...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4031500</comments>
            <pubDate>Tue, 05 Oct 2010 12:29:00 +0100</pubDate>
            <guid isPermaLink="false">4031500</guid>        </item>
        <item>
            <title>Pfizer &amp; The Largest Pole Erection In North America</title>
            <link>http://www.medworm.com/index.php?rid=3911867&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FuRHkwC75RlU%2F</link>
            <description>How&amp;#8217;s this for creative governing? The Toronto city council voted yesterday to call on Pfizer and Eli Lilly to help finance a 410-foot flagpole that would fly a Canadian flag the size of a football field in an industrial area, The National Post reports. The idea is to create a renowned monument, such as St. Peter’s Basilica in Rome or Trafalgar Square in London, by which the city would be known, according to the deputy mayor.
Local laws, however, prevent the local business improvement area from leasing or owning land, so the scheme is left to the city to buy the land where the flagpole would be erected. However, such a move would require as much as $10 million. To defray the cost, the council passed a resolution to seek corporate sponsorship from Pfizer and Lilly, since they have a...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3911867</comments>
            <pubDate>Fri, 27 Aug 2010 13:32:56 +0100</pubDate>
            <guid isPermaLink="false">3911867</guid>        </item>
        <item>
            <title>Forget Layoffs, Milwaukee Teachers Want Viagra</title>
            <link>http://www.medworm.com/index.php?rid=3831557&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FpsPxmCx5ruw%2F</link>
            <description>How&amp;#8217;s this for a budget battle? With all of the economic pain around the country, the Milwaukee teachers union has chosen an interesting issue over which to draw a line in the sand - they want a judge to order the school board to reinstate Viagra and other impotence pills in their health insurance plans. Never mind a financial crisis that may cause hundreds of union members to lose their jobs.
The filing is the latest in a two-year legal campaign in which the union has argued, so far unsuccessfully, that the board&amp;#8217;s policy of excluding impotence pills discriminates against male employees, the Associated Press writes. The union says Viagra, Cialis, Levitra and others are necessary treatment for &amp;#8220;an exclusively gender-related condition,&amp;#8221; and filed a lawsuit that was l...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3831557</comments>
            <pubDate>Fri, 06 Aug 2010 13:50:44 +0100</pubDate>
            <guid isPermaLink="false">3831557</guid>        </item>
        <item>
            <title>Cialis in glass and a shortage of helium</title>
            <link>http://www.medworm.com/index.php?rid=3794837&amp;cid=t_131625_107_f&amp;fid=36672&amp;url=http%3A%2F%2Fwww.sciencebase.com%2Fscience-blog%2Fcialis-erectile-dysfunction-helium-balloons.html</link>
            <description>These are my links for July 23rd through July 26th:

ACS and RSC Sustainability Alliance &amp;#8211; The Royal Society of Chemistry and the American Chemical Society have joined forces to launch a sustainability website. Be interesting to know what is the carbon footprint of this endeavour and the server electricity bills&amp;#8230;
Carcinogen suspects &amp;#8211; A new report from the American Cancer Society and other world-leading health groups identifies gaps in research for 20 suspected carcinogens whose potential to cause cancer is as yet unresolved. Of course, that research could prove that any one of those agents doesn&amp;#039;t actually cause cancer at all, which will be annoying for the activists. But, it&amp;#039;s the inclusion of &amp;quot;shift work&amp;quot; in the list that is perhaps most confusing? ...</description>
            <author>Sciencebase Science Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3794837</comments>
            <pubDate>Tue, 27 Jul 2010 12:00:19 +0100</pubDate>
            <guid isPermaLink="false">3794837</guid>        </item>
        <item>
            <title>An Important Tip For Men Who Use Viagra</title>
            <link>http://www.medworm.com/index.php?rid=3753822&amp;cid=t_131625_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fan-important-tip-for-men-who-use-viagra%2F2010.07.14</link>
            <description>The medical journal Mayo Clinic Proceedings recently contained some clinical pearls that I wanted to pass on to my men readers who take medication for erectile dysfunction (ED). They reported on a healthy 67-year-old male who took two 25mg doses of Viagra (sildenafil) but still did not get erections. He was frustrated and inquired about other treatments for ED.
The article reported that patients often take Viagra and other phosphodiesterase type 5 inhibitors (Cialis, Levitra) incorrectly. To be effective, Viagra must be taken on an empty stomach at least one hour before intercourse. Research has shown that approximately half of patients who don&amp;#8217;t respond to Viagra will have success when they take it properly. The dose can go up to 100mg, but there is no need to increase the medi...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3753822</comments>
            <pubDate>Wed, 14 Jul 2010 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">3753822</guid>        </item>
        <item>
            <title>Sex, Lies, and the Media: Did Businessweek Distort the Relation Between ED Drugs and STDs?</title>
            <link>http://www.medworm.com/index.php?rid=3730093&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F07%2Fsex-lies-and-media-did-businessweek.html</link>
            <description>The headline in a recent story reported in Bloomberg Businessweek tells it all: &quot;Men on Viagra, Cialis Show Triple Rate of Sex Diseases in Study.&quot; This was duly summarized in the Blogosphere on PharmaGossip:&quot;Men on Viagra, Cialis Show Triple Rate of Sex Diseases in Study - BusinessWeek&quot;Men taking drugs for sexual potency showed almost triple the rate of sexually transmitted diseases compared with those not taking the medications, a Harvard University study found.&quot;The results, from an analysis of the health insurance claims of men aged 40 and older, may have more to do with the nature of the men using the impotence drugs than with the medicines leading them to have riskier sex, the research report said. The study, looking at men taking Pfizer’s Inc. Viagra and Eli Lilly &amp; Co.’s Cial...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3730093</comments>
            <pubDate>Tue, 06 Jul 2010 12:14:00 +0100</pubDate>
            <guid isPermaLink="false">3730093</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=3730099&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FsAJ1_8Kfznw%2F</link>
            <description>Welcome back. We hope the long weekend was relaxing and refreshing. Some folks may still be on holiday, but for the rest of the us, the routine has returned. And so, we are preparing ourselves with a cup of stimulation. Please join us as we confront the usual deadlines and scan the news of the world. Meanwhile, have a great day, everyone&amp;#8230;
Contract Manufacturing To Grow At 12 Percent (OutsourcingPharma)
Sex Diseases Are Higher In Men Over 40 Taking ED Pills (Reuters)
Australia Reviews Genetic Testing For Cancer Drug (Sydney Herald)
Aspen To Lower Its Bid For Sigma Pharma (Bloomberg News)
AstraZeneca Strikes Deal With Academia (Financial Times)
Astellas Breaches ABPI Code Of Practice (PharmaTimes)
Atripla Co-Pay Program To Cover More People (POZ)
US Companies Eye British Takeover Targe...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3730099</comments>
            <pubDate>Tue, 06 Jul 2010 11:58:34 +0100</pubDate>
            <guid isPermaLink="false">3730099</guid>        </item>
        <item>
            <title>Now Hear This: Viagra Can Make You Deaf</title>
            <link>http://www.medworm.com/index.php?rid=3581843&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJL7-K-IyefE%2F</link>
            <description>UAB Study Examines Hearing Loss, Viagra Use from uabnews on Vimeo.
If at first you don&amp;#8217;t succeed&amp;#8230;.well, you know try again. A professor, whose earlier work indicating Viagra causes vision loss was discredited, has just published a new study that suggests the potential for long-term hearing loss after using Viagra and possibly similar drugs such as Cialis and Levitra, although results for those pills are inconclusive. The study is in the Archives of Otolaryngology-Head and Neck Surgery (see the abstract).
&amp;#8220;It appears from these findings that the current government warning regarding hearing loss and the use of PDE-5i medications is warranted,&amp;#8221; says Gerald McGwin, a professor of epidemiology in the UAB School of Public Health, in a statement. &amp;#8220;It has been hypothe...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3581843</comments>
            <pubDate>Wed, 19 May 2010 16:34:17 +0100</pubDate>
            <guid isPermaLink="false">3581843</guid>        </item>
        <item>
            <title>How To Steal Drugs: Cut A Hole In Lilly’s Roof</title>
            <link>http://www.medworm.com/index.php?rid=3370669&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F1Ah_knefTZY%2F</link>
            <description>That&amp;#8217;s what some enterprising thieves did over the weekend in Enfield, Ct., where the drugmaker maintains a non-descript building that actually functions as a distribution hub, according to local news reports. Unlike bank robbers who tunnel into a vault from below, this gang successfully clamored onto the roof, jumped in and drove off with about 70 pallets of Eli Lilly meds worth up to $75 million.
&amp;#8220;The hole was very high up and there was no way they you would be able to leap to the floor,&amp;#8221; Enfield Police Chief Carl Sferrazza tells WISH-TV. &amp;#8220;I don&amp;#8217;t want to get into the specific evidence that we found there but we believe that is how they gain entry into the building. We don&amp;#8217;t have a list of exactly what they took; there are pain killers involved; all pr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3370669</comments>
            <pubDate>Tue, 16 Mar 2010 12:32:46 +0100</pubDate>
            <guid isPermaLink="false">3370669</guid>        </item>
        <item>
            <title>Low Sex Drive? An Underarm Cream Will Do You</title>
            <link>http://www.medworm.com/index.php?rid=3370671&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHKCXYk7EypE%2F</link>
            <description>Looking to corner the market on improving your sex life, Eli Lilly has signed a deal with an Australian company called Acrux for the right to sell an underarm cream that can allegedly boost testerone levels. That&amp;#8217;s right. If you need a lift, you just lift your arm, shmear it on and off you go. Imagine the direct-to-consumer ads. However, this pertains to men over 45. The rest will have to use Cialis.
Results of a clinical trial released in September showed that, after four months, the Acrux cream helped 84 percent of patients achieve average blood levels of testosterone within the normal range. Acrux claims lowered testosterone affects 39 per cent of men over 45, with symptoms including decreased body mass and muscle strength, lowered libido and &amp;#8220;erectile quality,&amp;#8221; thinni...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3370671</comments>
            <pubDate>Tue, 16 Mar 2010 12:04:48 +0100</pubDate>
            <guid isPermaLink="false">3370671</guid>        </item>
        <item>
            <title>What Do Viagra &amp; Horny Goat Weed Have In Common?</title>
            <link>http://www.medworm.com/index.php?rid=3280189&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FN3csqoyskLk%2F</link>
            <description>Plenty, according to the US Patent and Trademark Office, which partially rejected the patent on Pfizer&amp;#8217;s little blue impotence pill after deciding a chemical ingredient in the herb is a similar type of enzyme inhibitor found in Viagra, Bloomberg News reports.
A PTO appeals board last Friday upheld a decision that an element, or claim, of the patent for a method of treating impotence didn’t cover a new invention. The patent claim was key to an infringement suit Pfizer filed in 2002 against Lilly over its rival Cialis drug. The decision, posted on the PTO’s Web site, can be appealed, Bloomberg continues. The patent expires in 2019, and Pfizer has another patent on Viagra that expires in 2012. 
A Pfizer spokesman tells Bloomberg other elements of the patent remain valid and the deci...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3280189</comments>
            <pubDate>Wed, 17 Feb 2010 13:24:49 +0100</pubDate>
            <guid isPermaLink="false">3280189</guid>        </item>
        <item>
            <title>Hallelujah! The Recession is Over! Sales of &quot;Lifestyle&quot; Drugs Like Botox &amp; Cialis On the Rebound.</title>
            <link>http://www.medworm.com/index.php?rid=3251393&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2010%2F02%2Fhallelujah-recession-is-over-sales-of.html</link>
            <description>As reported over at minyanville.com (&quot;Sign of the Times? Cosmetic Surgery Is Back&quot;):According to a survey done by MEDACorp, plastic surgery and cosmetic procedures were up during the fourth quarter [of 2009] for the first time since the downturn began in 2007.The survey encompassed facial injectibles, breast implants, laser procedures, and Latisse for eyelash growth. The results of the survey indicated that procedures for botulinum toxins like Allergan’s (AGN) Botox and facial fillers like Medicis Pharmaceutical’s (MRX) Restylane increased the most year-over-year in the fourth quarter of 2009, each up 8.1%. Procedures for breast implants increased 3.5% and laser work was up 1.6%.Cialis is also having a good year, reported the IndyStar (see &quot;Lilly's Cialis meets with success, challenges...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3251393</comments>
            <pubDate>Mon, 08 Feb 2010 15:15:00 +0100</pubDate>
            <guid isPermaLink="false">3251393</guid>        </item>
        <item>
            <title>DTC Ads Drove Website Traffic To These Brands…</title>
            <link>http://www.medworm.com/index.php?rid=3197885&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F_5l-Xitz6Rs%2F</link>
            <description>For those wondering about the reactions that some consumers have to DTC television ads, some decide to search for more info online. So which ads are prompting the most activity and which product sites are visited? NuvaRing and Latisse had the highest percentage of overall product website traffic driven by their DTC TV ads, according to Manhattan Research.
NuvaRing, which is a contraceptive made by Merck, jumped five spots from last year to take the top ranking. And as you can see, Allergan&amp;#8217;s new eyelash enhancement treatment, Latisse, grabbed the No. 2 spot. Unfortunately, there was no corresponding info to contrast the amount of ad spending with web traffic. In any event, here is the list of the ten brands for which DTC ads drove the most web traffic&amp;#8230;
1.  NuvaRing
2.  Latisse
...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3197885</comments>
            <pubDate>Fri, 22 Jan 2010 13:19:09 +0100</pubDate>
            <guid isPermaLink="false">3197885</guid>        </item>
        <item>
            <title>As seen on TV - Pharma's top websites</title>
            <link>http://www.medworm.com/index.php?rid=3176121&amp;cid=t_131625_150_f&amp;fid=38374&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2F1fcV9LKHq8w%2Fas-seen-on-tv-pharmas-top-websites.html</link>
            <description>(Source: ePharma Summit)</description>
            <author>ePharma Summit</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3176121</comments>
            <pubDate>Thu, 14 Jan 2010 19:23:00 +0100</pubDate>
            <guid isPermaLink="false">3176121</guid>        </item>
        <item>
            <title>Impotence Pill Makers Fined For Price Fixing</title>
            <link>http://www.medworm.com/index.php?rid=3045022&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fl_nzGtSnEiw%2F</link>
            <description>File this under stiff fine. The Swiss Competition Commission, which is known as WEKO, has tagged the Swiss units of Pfizer, Lilly and Bayer a total of $5.7 million for fixing the prices of their erectile dysfunction drugs - Viagra, Cialis and Levitra - through public price recommendations. These recommendations are usually made by pharmacies and medical practitioners, are illegal, Dow Jones writes. Bayer rejected the charge.
Earlier this year, WEKO concluded a 2006 investigation by deciding that the publication and observance of recommended retail prices for the pills represented illegal vertical collusion between the drugmakers and distributors. At the time, this was the biggest investigation to be undertaken by WEKO, which recommended sanctions. Whether $5.7 million in collective fines c...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3045022</comments>
            <pubDate>Tue, 01 Dec 2009 12:58:43 +0100</pubDate>
            <guid isPermaLink="false">3045022</guid>        </item>
        <item>
            <title>Stiff fines?</title>
            <link>http://www.medworm.com/index.php?rid=3045017&amp;cid=t_131625_150_f&amp;fid=34768&amp;url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2009%2F12%2Fstiff-fines.html</link>
            <description>The Swiss branches of Pfizer Inc., Eli Lilly &amp; Co. and Bayer AG were fined a total of 5.7 million francs (dollars) by competition regulators on Tuesday for alleged price fixing of drugs for erectile dysfunction.More (Source: PharmaGossip)</description>
            <author>PharmaGossip</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3045017</comments>
            <pubDate>Tue, 01 Dec 2009 11:36:00 +0100</pubDate>
            <guid isPermaLink="false">3045017</guid>        </item>
        <item>
            <title>Flomax Was Most-Recalled Drug Ad On TV</title>
            <link>http://www.medworm.com/index.php?rid=2963331&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FMKV_4dafnTc%2F</link>
            <description>Two commercials for Flomax topped the ranking of the most recalled drug and vaccine ads during the 2008-09 TV season, according to a Nielsen analysis. The Boehringer-Ingelheim drug, which treats male urinary symptoms due to BPH, ran two ads that were recalled at a rate that was 42 percent greater than the average ad based on all newly-launched prescription drug ads. The latest installments of the Flomax DTC campaign feature men at a baseball game and men playing on a golf course.
Lilly&amp;#8217;s Cialis and Merck&amp;#8217;s Gardasil tied for second on the list with 32 percent greater recall than the average drug ad launched last season. The Cialis ad was an extension of its “What are you waiting for?” campaign and featured outdoor tubs filled with various couples (you know the imagery by now...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2963331</comments>
            <pubDate>Thu, 05 Nov 2009 12:53:45 +0100</pubDate>
            <guid isPermaLink="false">2963331</guid>        </item>
        <item>
            <title>Viagra Failed? Let Medtronic Prop You Up</title>
            <link>http://www.medworm.com/index.php?rid=2890944&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrkA_R7kM9eo%2F</link>
            <description>The little blue pill may not work for everyone, so what&amp;#8217;s a guy to do? Maybe get a stent in order to, you guessed it, get a lift. Medtronic is conducting a small study to see if using a stent to prop open arteries near the penis can help men with erectile dysfunction, according to the device maker (here&amp;#8217;s the statement).
The one-year study will include 50 patients at up to 10 U.S. medical centers. Studies have shown that up to half of the 25 million U.S. men who suffer from erectile dysfunction don&amp;#8217;t respond to Viagra or Lilly&amp;#8217;s Cialis, Jason Rogers, a cardiologist at the University of California at Davis Medical Center in Sacramento, tells Bloomberg.
&amp;#8220;There is an unmet clinical need for some other therapy to help these men,&amp;#8221; says Rogers, who is a resear...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2890944</comments>
            <pubDate>Tue, 13 Oct 2009 21:41:30 +0100</pubDate>
            <guid isPermaLink="false">2890944</guid>        </item>
        <item>
            <title>Cialis Ads Make a Splash, But Sales are Down</title>
            <link>http://www.medworm.com/index.php?rid=2349718&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F04%2Fcialis-ads-make-splash-but-sales-are.html</link>
            <description>Although Lilly's profits rose 23% primarily due to a 27% decrease in sales costs (see &quot;Eli Lilly Profit Rises 23%&quot;), &quot;Q1 sales of Cialis, Cymbalta, Zyprexa, Humalog, Gemzar all DOWN from Q4 to Q1,&quot; reported CNBC Pharmaceuticals Reporter Mike Huckman on Twitter (see @mhukman).Meanwhile, Lilly continues to spend hundreds of millions of dollars on DTC (direct-to-consumer) advertising for Cialis, its erectile dysfunction (ED) drug.According to IndyStar.com, &quot;Cialis was the seventh-most-advertised drug in the country in 2007, with $152 million spent.&quot;Although sales of Cialis are down recently -- possibly reflecting less discretionary income spending on life-style drugs during this recession -- Cialis is catching up to Viagra. Worldwide sales of Cialis last year increased by 26 percent, to $1.4 ...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2349718</comments>
            <pubDate>Mon, 20 Apr 2009 11:59:00 +0100</pubDate>
            <guid isPermaLink="false">2349718</guid>        </item>
        <item>
            <title>Lilly's Cialis Campaign Wins &quot;Marketing Overdose Award&quot;</title>
            <link>http://www.medworm.com/index.php?rid=2011122&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F12%2Flillys-cialis-campaign-wins-marketing.html</link>
            <description>Eli Lilly takes this year's Marketing Overdose Award for the promotion of its erectile dysfunction (ED) drug, Cialis. The award was given by Consumers International (CI), a non-profit international consumer advocacy group with member organizations in 220 countries (ie, Consumers Union in the US).&quot;Eli Lilly has run foul of marketing regulations in the promotion of it's erectile dysfunction (ED) drug Cialis on a number of occasions around the world,&quot; states CI (see &quot;Eli Lilly -- The Marketing Overdose Award for rampant promotion&quot;). &quot;In October 2008, the UK [Prescription Medicines Code of Practice Authority] reprimanded Lilly for not providing adequate information about the side effects of Cialis in its online and in-surgery promotions. The online information site was linked to the first ever...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2011122</comments>
            <pubDate>Thu, 04 Dec 2008 11:54:00 +0100</pubDate>
            <guid isPermaLink="false">2011122</guid>        </item>
        <item>
            <title>Lilly's &quot;40 over 40&quot; Erectile Dysfunction Campaign is a &quot;Discredit on the Industry&quot; Says UK Watchdog</title>
            <link>http://www.medworm.com/index.php?rid=1960709&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F11%2Flillys-40-over-40-erectile-dysfunction.html</link>
            <description>According to an article in the London Financial Times:&quot;Eli Lilly is to be reprimanded by the UK pharmaceutical industry watchdog for 'unbalanced' promotion of its anti-erectile dysfunction drug Cialis, in violation of ethical rules.&quot;The Prescription Medicines Code of Practice Authority has ruled that the US-based company 'brought discredit' on the industry through a marketing campaign on television, the internet and in brochures in GP surgeries in the UK.&quot;The Lilly campaign that is the focus of this reprimand is the so-call “40 over 40” campaign, which claims that &quot;40 per cent of men aged over 40 had problems with erectile dysfunction.&quot;It's interesting that the UK &quot;watchdog&quot; focused on the failure of the campaign &quot;to cite the side-effects or risks, and in a way that would have encourag...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1960709</comments>
            <pubDate>Thu, 13 Nov 2008 15:10:00 +0100</pubDate>
            <guid isPermaLink="false">1960709</guid>        </item>
        <item>
            <title>Coming soon!</title>
            <link>http://www.medworm.com/index.php?rid=1837175&amp;cid=t_131625_150_f&amp;fid=34768&amp;url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2008%2F09%2Fcoming-soon.html</link>
            <description>A new internet service which allows men in the UK to get erectile dysfunction drugs such as Viagra, Cialis and Levitra legitimately and without a prescription has been launched, in a move that could stem the tide of fake drugs being sold online.The service, a first for the country, is being launched by Lloydspharmacy in partnership with sexual health experts Dr Thom. It offers online diagnosis of erectile problems and the subsequent dispensing of prescriptions via the internet.Andy Murdock, pharmacy director of Lloydspharmacy said that the service will give men “the confidence to use the internet for ED treatments, safe in the knowledge that they will be receiving genuine drugs from a reliable source” .He noted that many men use the net to buy ED drugs but “unfortunately, most online...</description>
            <author>PharmaGossip</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1837175</comments>
            <pubDate>Mon, 29 Sep 2008 11:42:00 +0100</pubDate>
            <guid isPermaLink="false">1837175</guid>        </item>
        <item>
            <title>Cialis Ads Lure Younger Men: Consumer Reports</title>
            <link>http://www.medworm.com/index.php?rid=1516783&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F311175509%2F</link>
            <description>In the latest installment of its Video Watch, the consumer watchdog picks over the ubiquitous TV ad for Lilly&amp;#8217;s Cialis, the erectile dysfunction pill, which is known as &amp;#8216;The Weekender&amp;#8217; spot.
And the results of a survey of about 1,500 men are interesting - about half thought the men who appear in the ads look to be in their 40&amp;#8217;s. Of course, ED is prevalent mostly in men 60 years and older. The younger-looking actors may explain why younger men in the survey asked their docs about Cialis after seeing the ad, notes CR. In other words, the TV spot works. 
Other results - about one-quarter of the survey participants thought all men could benefit from cialis, even if they don&amp;#8217;t have ED. And as the narrator notes, the voiceover and fine print don&amp;#8217;t mention that...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1516783</comments>
            <pubDate>Fri, 13 Jun 2008 14:11:22 +0100</pubDate>
            <guid isPermaLink="false">1516783</guid>        </item>
        <item>
            <title>Lilly Backs Bill Requiring Payment Disclosure</title>
            <link>http://www.medworm.com/index.php?rid=1440004&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F289666118%2F</link>
            <description>The drugmaker is on what it calls a transparency kick. Having already created registries listing clinical trials and grants, Lilly is apparently the first big drugmaker to back the Physicians Payments Sunshine Act, which would establish a national registry of payments to docs by drug and device makers.
Drug and device makers have been under pressure to take such steps. You may recall a dozen drug and device makers last month told Chuck Grassley, the Iowa Republican and a co-sponsor of the bill, that they would publicly disclose grants to outside groups, and the details will be provided on each company’s web site. And as part of a settlement with the Department of Justice, five device makers agreed to post consultant payments on their web sites.
In a statement, Herb Kohl, a Wisconsin Demo...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1440004</comments>
            <pubDate>Tue, 13 May 2008 20:13:49 +0100</pubDate>
            <guid isPermaLink="false">1440004</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Morning</title>
            <link>http://www.medworm.com/index.php?rid=1327603&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F258253610%2F</link>
            <description>The middle of the week is here and that can mean only one thing - plenty to do. Meetings, deadlines, projects. The list is long. So is ours. All of which tells us that the time has come for our daily cup of stimulation as we peruse the news of the world. Here are some of the latest developments to help you keep up. Hope your day goes well&amp;#8230;
Pfizer Sues Ranbaxy To Delay Generic Lipitor, Caduet (Bloomberg News)
Sanofi Strikes Deal To Market Lilly&amp;#8217;s Cialis In US (Bloomberg News)
NIH Vows To Back AIDS Research (The Baltimore Sun)
Denmark, France &amp;#038; Italy Recall Heparin (The Wall Street Journal)
UK&amp;#8217;s NICE Approves Sanofi&amp;#8217;s Acomplia Diet Pill (Yahoo/Reuters)
Vioxx Deadline Extended By One Month (BusinessWeek) (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1327603</comments>
            <pubDate>Wed, 26 Mar 2008 10:58:57 +0100</pubDate>
            <guid isPermaLink="false">1327603</guid>        </item>
        <item>
            <title>Today's Spitzer moment bought to you by Cialis</title>
            <link>http://www.medworm.com/index.php?rid=1314098&amp;cid=t_131625_150_f&amp;fid=34768&amp;url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2008%2F03%2Ftodays-spitzer-moment-bought-to-you-by.html</link>
            <description>Cialis - time for both wife and hooker!Ashley Alexandra Dupre Gone Wild - The Huff Po. (Source: PharmaGossip)</description>
            <author>PharmaGossip</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1314098</comments>
            <pubDate>Wed, 19 Mar 2008 18:40:00 +0100</pubDate>
            <guid isPermaLink="false">1314098</guid>        </item>
        <item>
            <title>Viagra for what???</title>
            <link>http://www.medworm.com/index.php?rid=1312352&amp;cid=t_131625_117_f&amp;fid=34612&amp;url=http%3A%2F%2Fwww.thedoctorweighsin.com%2Fjournal%2F2008%2F3%2F18%2Fviagra-for-what.html</link>
            <description>By Dov Michaeli MD, Ph.D Viagra can perk up&amp;hellip; no, no what you think. Rejoice all ye travelers: Viagra will perk you up and shorten your jet lag if you go from West to East. How does it work? The biological clock This concept needs no introduction: most animals gear their activities to the light-dark (LD) cycles. In mammals this &amp;ldquo;biological clock&amp;rdquo; resides in a specific area of the brain, called the suprachiasmatic nuclei (SCN). The principal signal that adjusts the biological clock with the environment is the LD cycle. But how does an area deep inside the brain sense light? Of course, you would say. Don&amp;rsquo;t we have an optic nerve that transmits images from the retina to the brain?But, if that were the mechanism, blind people would not have been entrained (synchronized)...</description>
            <author>The Doctor Weighs In</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1312352</comments>
            <pubDate>Tue, 18 Mar 2008 20:46:34 +0100</pubDate>
            <guid isPermaLink="false">1312352</guid>        </item>
        <item>
            <title>The Top 10 Product Websites</title>
            <link>http://www.medworm.com/index.php?rid=1222427&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F233303328%2F</link>
            <description>Who doesn&amp;#8217;t like a list? This one shows the ranking of branded drug sites that drove consumer requests for prescriptions and is based on a survey of 5,112 adults in the US, according to Manhattan Research. Most likely, you won&amp;#8217;t find it surprising that the sites are for meds that treat such afflictions as impotence, insomnia and nicotine addiction.
1 - Chantix
2 - Cialis
3 - Viagra
4 - Aciphex
5 - Ambien CR
6 - Levitra
7 - Lamisil
8 - Lunesta
9 - Wellbutrin XL
10 - Ortho Evra (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1222427</comments>
            <pubDate>Mon, 11 Feb 2008 19:11:00 +0100</pubDate>
            <guid isPermaLink="false">1222427</guid>        </item>
        <item>
            <title>Patents: Here A Challenge, There A Challenge</title>
            <link>http://www.medworm.com/index.php?rid=1218235&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F231590834%2F</link>
            <description>AstraZeneca is trying to head off the threat of generic competition to its blockbuster Seroquel schizophrenia drug by seeking a summary judgment in a lawsuit in federal court in New Jersey. Teva Pharmaceuticals is challenging Seroquel patents and could launch in the US as early as the end of March, once a 30-month stay on approval is lifted. Such an early launch would leave Teva exposed to paying damages if a court later backed AstraZeneca&amp;#8217;s patent position, but generic companies are increasingly pursuing such &amp;#8220;at risk&amp;#8221; launches. Seroquel had sales of $4 billion last year. (Read more).
Ranbaxy Laboratories received tentative FDA approval for a generic version of AstraZeneca&amp;#8217;s Nexium heartburn med. The generic drugmaker has first-to-file status, providing a potential...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1218235</comments>
            <pubDate>Fri, 08 Feb 2008 13:01:35 +0100</pubDate>
            <guid isPermaLink="false">1218235</guid>        </item>
        <item>
            <title>Lilly Loses Court Bid To Stop Internet Sales</title>
            <link>http://www.medworm.com/index.php?rid=1208099&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F229622411%2F</link>
            <description>The drugmaker has been trying to stop a UK pharmacy, which is buying Lilly drugs in Turkey, from selling them to Internet pharmacies in Canada. But London&amp;#8217;s High Court threw out the case, Reuters reports.
The move is a big setback Lilly, which hoped to plug a cut-price route for med reaching the US. But faced with some of the highest drug prices in the world, many US patients have resorted to Canadian Internet pharmacies, which can offer discounts of as much as 80 percent by buying drugs for a lower price from other countries. The trademarks at the center of the case were the Lilly name, as well as the drug names Cialis, Evista, Humulin and Humalog. Evista is a drug for osteoporosis and Humalog and Humulin are for diabetes. And Cialis is for impotence.
In November, Lilly won a tempor...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1208099</comments>
            <pubDate>Tue, 05 Feb 2008 14:29:51 +0100</pubDate>
            <guid isPermaLink="false">1208099</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Evening, All</title>
            <link>http://www.medworm.com/index.php?rid=1187239&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F225618605%2F</link>
            <description>And so another busy day winds down. We hope yours was as productive as ours. After all, something is always happening. We even had time to catch lunch with a couple of industry types (and, yes, we paid for ourselves). And now, on to the evening and some bedtime reading with one of the short people. Catch you in the morning&amp;#8230;
Hundreds of Florida residents who claim Vioxx caused their strokes or heart attacks were squeezed out the $4.85 billion settlement and have filed a motion to be included, the Associated Press reports. If the motion is successful, people in a half-dozen other states - which, like Florida, give residents more than three years to file personal injury lawsuits - might also be added to the deal. But a Merck lawyer and a plaintiffs&amp;#8217; lawyers say Florida residents w...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1187239</comments>
            <pubDate>Wed, 30 Jan 2008 07:05:13 +0100</pubDate>
            <guid isPermaLink="false">1187239</guid>        </item>
        <item>
            <title>Look Out for Sexier Cialis Ads -- Maybe Including Beaver!</title>
            <link>http://www.medworm.com/index.php?rid=1155880&amp;cid=t_131625_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2008%2F01%2Flook-out-for-sexier-cialis-ads-maybe.html</link>
            <description>Now that the FDA has approved Cialis for once daily use for the treatment of erectile dysfunction (ED; see Lilly press release), expect to see a twist to direct-to-consumer (DTC) ads for the drug: sexier late- night ads!Lately, almost all ED drug ads -- especially Cialis and Levitra ads -- are focusing a lot more on the women in the ads. Not in any kind of prurient manner as yet, but showing them fairly jumping on their male companions' bones, if you know what I mean. They're acting like horny teenage girls! But it's still very sweet and loving.ED ads have progressed from older celebrity male endorsers (eg, Bob Dole) to younger male actors only hinting at having a better sex life (Viagra's Joe commercials) to ads that include couples on the verge of having sex. Now, we are about to progres...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1155880</comments>
            <pubDate>Wed, 16 Jan 2008 11:39:00 +0100</pubDate>
            <guid isPermaLink="false">1155880</guid>        </item>
        <item>
            <title>Eli Lilly and Co. Gets FDA Approval for Once-Daily Cialis</title>
            <link>http://www.medworm.com/index.php?rid=1139828&amp;cid=t_131625_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F213935760%2Feli_lilly_and_co_gets_fda_appr.html</link>
            <description>Eli Lilly &amp; Co.&amp;nbsp;(NYSE:LLY) announced that the U.S. Food and Drug Administration has approved two low-dose forms of Cialis for use on a daily basis.Cialis, an anti-impotence drug, will now be available in 2.5 milligram and 5 milligram doses and will allow men more flexibility in the timing of sexual activity.&amp;quot;In clinical trials, when taken without restrictions on the timing of sexual activity, Cialis for once daily use improved erectile function over the course of therapy,&amp;quot; Lilly said in a release.The low-dose formulations have already been available in parts of Europe but the company warns that even the new reduced dosage makes the medication inappropriate for heart patients who take nitrates. The combination of sildenafil citrate (Viagra), tadalafil (Cialis) or vardenaf...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1139828</comments>
            <pubDate>Wed, 09 Jan 2008 16:00:26 +0100</pubDate>
            <guid isPermaLink="false">1139828</guid>        </item>
        <item>
            <title>Once-A-Day Cialis May Give Rise To Shealis</title>
            <link>http://www.medworm.com/index.php?rid=1137217&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F213322956%2F</link>
            <description>The FDA has approved a new formulation of the impotence pill that is likely to be quite popular, since the latest version allows men to &amp;#8220;attempt sexual activity at anytime between doses,&amp;#8221; as Lilly says in its statement. The new 2.5 or 5mg dose is a boon for guys who hope to have more sex, about twice a week, in fact, the drugmaker calculates.
Until now, Cialis has been taken as needed - the 5, 10 and 20 mg dosages provide effectiveness for up to 36 hours. This may be good news for Lilly shareholders, men or women, because the new pill won&amp;#8217;t come cheap. A month&amp;#8217;s supply of the existing 5 mg dose costs about $350 or so. Insurers, however, may not be happy. And don&amp;#8217;t forget that little problem about a hearing loss.
But about women who will be concerned that once-...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1137217</comments>
            <pubDate>Tue, 08 Jan 2008 17:48:24 +0100</pubDate>
            <guid isPermaLink="false">1137217</guid>        </item>
        <item>
            <title>Cialis Safe and Effective For Men with Spinal Cord Injury</title>
            <link>http://www.medworm.com/index.php?rid=1027136&amp;cid=t_131625_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F184829236%2Fcialis_safe_and_effective_for.html</link>
            <description>Dr. Francois Giuliano of Raymond Poincare Hospital, Garches, France and colleagues conducted a study whose results show that Eli Lily&amp;#39;s (NYSE:LLY) Cilais is safe and effective for men with spinal cord injuries who have erectile difficulties.186 men were randomly assigned either Cialis (tadalafil)&amp;nbsp;or a placebo for a 12 week period. Of the 126 men in the treatment group that completed the study, almost 85% found that the drug improved their erections compared to just under 20% of those on placebo. 78.5% also said that it improved their ability to engage in sexual activity.This may offer men with spinal cord injury and their partners a &amp;quot;more natural sexual experience,&amp;quot; they add. &amp;quot;Hence, tadalafil may be the agent of choice for spinal cord injury patients who do not wan...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1027136</comments>
            <pubDate>Wed, 14 Nov 2007 19:30:42 +0100</pubDate>
            <guid isPermaLink="false">1027136</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Stretch Your Bones</title>
            <link>http://www.medworm.com/index.php?rid=1021389&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F183744416%2F</link>
            <description>As we gaze out the window here in the nation&amp;#8217;s medicine chest we see nothing but gray skies. Not the nicest day for a walk in the park or a stroll around the Pharmalot corporate campus. What better way, then, to perk up than to get in sync with the world at large? Here are a few events that should help&amp;#8230;.
Amgen Receives Subpoenas From US Attorneys (Yahoo/AP)
Herbal Sex Pills Pose Hidden Dangers (Yahoo/AP)
Abbott&amp;#8217;s Kaletra AIDS Drug Approved By FDA For Pediatric Use (Yahoo/AP)
VaxGen Narrows Its Losses (bizjournals.com)
Novavax Losses Rise On R&amp;#038;D Costs (bizjournals.com)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1021389</comments>
            <pubDate>Mon, 12 Nov 2007 20:36:38 +0100</pubDate>
            <guid isPermaLink="false">1021389</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Evening Edition</title>
            <link>http://www.medworm.com/index.php?rid=970220&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F173545947%2F</link>
            <description>A busy day, this was. Computer problems. Earnings. Novel legislation. And mysterious letters. We hope you had as much fun as we did (except for the computer problem, that is). Now, the time has come to regroup and prepare for tomorrow. Of course, we will return shortly with more for you to digest. There is always something interesting rumbling around out there, after all. But meanwhile, please enjoy these&amp;#8230;
New Warnings Won&amp;#8217;t Sink Erectile Dysfunction Drugs (The Motley Fool)
Glaxo Has Sold 2 Million Alli Starter Kits Since June (International Herald Tribune)
Bioenvision Shareholders Approve Genzyme Offer (Yahoo/AP)
Sepracor Stock Falls On Analyst Downgrade (Associated Press)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=970220</comments>
            <pubDate>Mon, 22 Oct 2007 23:48:33 +0100</pubDate>
            <guid isPermaLink="false">970220</guid>        </item>
        <item>
            <title>Viagra: Great Sex, But I Can’t Hear A Thing</title>
            <link>http://www.medworm.com/index.php?rid=961801&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F171823525%2F</link>
            <description>Imagine the scenario. They&amp;#8217;re all done, she asks how it was - and he doesn&amp;#8217;t say a thing. Why? He can&amp;#8217;t hear her. She&amp;#8217;s not pleased. But the real reason may have been an unusual case of sudden hearing loss, courtesy of Pfizer&amp;#8217;s little blue pill. The FDA, in fact, is now warning about the risk associated with all three erectile dysfunction meds - which means Cialis and Levitra, too.
The FDA posted a new info on its web site, noting that a publicized case prompted a review that found 29 instances associated with all three drugs. In one-third of the cases, hearing loss was temporary, but the remaining cases were ongoing at the time of the review, Reuters notes. It&amp;#8217;s not known if age was a factor, but all three drugs, plus Pfizer&amp;#8217;s Revatio, a version o...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=961801</comments>
            <pubDate>Fri, 19 Oct 2007 00:06:50 +0100</pubDate>
            <guid isPermaLink="false">961801</guid>        </item>
        <item>
            <title>Lilly Gets A Lift From Cialis: Earnings Are Up</title>
            <link>http://www.medworm.com/index.php?rid=959857&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F171582475%2F</link>
            <description>The drugmaker reports that quarterly profits rose 6 percent, and thanks a 47 percent gain in sales of the Cymbalta antidepressant and a 27 percent increase in sales of Cialis, the erectile dysfunction pill. In the past, Lilly didn&amp;#8217;t capture all Cialis sales, because the med belong to Icos, but the drugmaker bought Icos earlier this year.
As a result, net income increased to $926.3 million, or 85 cents a share, from $873.6 million, or 80 cents, a year earlier. Revenue rose 19 percent to $4.6 billion partner. Cymbalta sales, by the way, reached $513.2 million and Cialis notched $311.4 million in revenue. Lilly&amp;#8217;s biggest seller, the Zyprexa antipsychotic, posted an 8 percent increase in sales to $1.17 billion, but that reflected a price increase earlier this year. (See complete re...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=959857</comments>
            <pubDate>Thu, 18 Oct 2007 12:38:15 +0100</pubDate>
            <guid isPermaLink="false">959857</guid>        </item>
        <item>
            <title>Lilly Discloses All Clinical Trials, Really. Except…</title>
            <link>http://www.medworm.com/index.php?rid=944710&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F168440413%2F</link>
            <description>In a speech last week, Lilly ceo Sid Taurel spoke about an information revolution in healthcare and, as part of that, how health professionals and drugmakers could contribute to patient needs by making better use of data at their disposal. Toward that end, he made a point of noting how Lilly discloses clinical trial results, a hot-button issue given that the industry has been accused of failing to release unfavorable data. 
&amp;#8220;Three years ago, Lilly became the first pharmaceutical company to publicly disclose the results of all (emphasis added) of our clinical trials – on the Internet. Far from harming our business in some way, I’m convinced that the increased transparency helped to improve our partnerships with researchers and to boost the confidence of doctors and patients who us...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=944710</comments>
            <pubDate>Thu, 11 Oct 2007 13:37:44 +0100</pubDate>
            <guid isPermaLink="false">944710</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Good Evening</title>
            <link>http://www.medworm.com/index.php?rid=858558&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F154788881%2F</link>
            <description>A very busy day, it was. And so we offer you still more items to help you remain acclimated. Meanwhile, the time has come for us to catch up on reading of our own. Until next time&amp;#8230;.
Cialis Boosts Sex After Spinal-Cord Injury (Yahoo/Reuters)
Wyeth Whistleblower&amp;#8217;s Revelations No Bearing On Sarbanes-Oxley (CCH.com)
Pfizer Sees Lipitor Sales At Low End Of Forecast (Yahoo/AP)
Medarex Skin Cancer Drug May Miss The Mark (TheStreet.com)
&amp;#8216;Academic Detailers&amp;#8217; Offer Docs An Alternative (The Star-Ledger of New Jersey)
Share / E-mail (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=858558</comments>
            <pubDate>Mon, 10 Sep 2007 22:50:48 +0100</pubDate>
            <guid isPermaLink="false">858558</guid>        </item>
        <item>
            <title>Pfizer Computers Spewing Viagra Spam!</title>
            <link>http://www.medworm.com/index.php?rid=847521&amp;cid=t_131625_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F153014168%2F</link>
            <description>Pfizer&amp;#8217;s computer network is spamming the Internet with e-mails and touting Viagra, along with ads for knockoff Rolexes and shady junk stocks, Wired reports, adding that the e-mails aren&amp;#8217;t part of Pfizer&amp;#8217;s official marketing efforts.
The drugmaker&amp;#8217;s computers appear to have been infected with malware that has transformed them into &amp;#8216;zombie computers&amp;#8217; that send spam at the behest of a hacker. Oddly enough, they are spamming the public&amp;#8217;s inboxes with ads for the company&amp;#8217;s own product. &amp;#8220;There is a disaster inside this company, and they don&amp;#8217;t know it,&amp;#8221; says Rick Wesson, CEO of Support Intelligence, a security company that alerted Wired News to the problem.
Much of the spam originating from Pfizer computers pretends to be sent fro...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=847521</comments>
            <pubDate>Thu, 06 Sep 2007 15:26:14 +0100</pubDate>
            <guid isPermaLink="false">847521</guid>        </item>
        <item>
            <title>Is Viagra good for the heart?</title>
            <link>http://www.medworm.com/index.php?rid=733646&amp;cid=t_131625_87_f&amp;fid=34866&amp;url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F07%2F13%2Fis-viagra-good-for-the-heart%2F</link>
            <description>Filed under: Men Heart HealthHere's some uplifting news: The men in those Viagra commercials have another reason to be happy -- they're doing something good for their heart by taking the drug. In fact, a study at the University of Alberta has even found that patients with a potentially fatal condition, a failing right ventricle of the heart, can improve by taking the drug. The magic heart-healthy ingredient in Viagra and other erectile-dysfunction drugs is phosphodiesterase type 5 inhibitors, although I suspect that the extra 'activity' that comes with taking Viagra probably has a healthy effect on the heart too.Read&amp;nbsp;|&amp;nbsp;Permalink&amp;nbsp;|&amp;nbsp;Email this&amp;nbsp;|&amp;nbsp;Linking&amp;nbsp;Blogs&amp;nbsp;|&amp;nbsp;Comments (Source: The Cardio Blog)</description>
            <author>The Cardio Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=733646</comments>
            <pubDate>Fri, 13 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">733646</guid>        </item>
    </channel>
</rss>

